Danish Pharmacovigilance Update, April 2016

10 May 2016

News from the EU

  • The European Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of the risk of amputations in connection with canagliflozin treatment
  • EU's list of recommendations on safety signals

News from the Danish Medicines Agency

  • Reports of cardiac arrest after treatment with methylphenidate
  • Influenza vaccines and reports of suspected adverse reactions

Short news

  • Most recent Direct Healthcare Professional Communications (DHPCs)
  • Information material for healthcare professionals and patients about biological medicines and biosimilars

Link

Danish Pharmacovigilance Update April 2016 (pdf)

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.